RET mutations in neuroendocrine tumors: Including small-cell lung cancer

Journal of Thoracic Oncology

Volumn 9, Issue 9, 2014, Pages 1240-1242

  Rudin, Charles M ^a   Drilon, Alexander ^a   Poirier, J T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN P53; PROTEIN RET; PROTEIN TYROSINE KINASE; RETINOBLASTOMA PROTEIN; RET PROTEIN, HUMAN; RNA;

CANCER SURVIVAL; CELL PROLIFERATION; FINE NEEDLE ASPIRATION BIOPSY; GANGLIONEUROMA; GENE FUSION; GENE MUTATION; GENE OVEREXPRESSION; GENE REARRANGEMENT; HUMAN; HUMAN GENOME; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; LUNG ADENOCARCINOMA; LUNG SMALL CELL CANCER; MISSENSE MUTATION; NEUROENDOCRINE TUMOR; NEUROFIBROMATOSIS; NONHUMAN; ONCOGENE RET; OVERALL SURVIVAL; PARATHYROID ADENOMA; PARATHYROID HYPERPLASIA; PHENOTYPE; PHEOCHROMOCYTOMA; PRIMARY TUMOR; PRIORITY JOURNAL; RADIATION EXPOSURE; REVIEW; SIGNAL TRANSDUCTION; SIPPLE SYNDROME; SOMATIC MUTATION; SURVIVAL RATE; THYROID MEDULLARY CARCINOMA; THYROID PAPILLARY CARCINOMA; TUMOR LOCALIZATION; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MUTATION; SMALL CELL LUNG CANCER;

GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MUTATION; PROTO-ONCOGENE PROTEINS C-RET; RNA, NEOPLASM; SMALL CELL LUNG CARCINOMA;

EID: 84906238714     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000301     Document Type: Editorial

References (15)

1. Fusco A, Grieco M, Santoro M, et al. A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases. Nature 1987;328:170-172.
2. Omur O, Baran Y. An update on molecular biology of thyroid cancers. Crit Rev Oncol Hematol 2014;90:233-252.
3. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
4. Takeuchi K, Soda M, Togashi Y, et al. RET, ROS1 and ALK fusions in lung cancer. Nat Med 2012;18:378-381.
5. Ju YS, Lee WC, Shin JY, et al. A transforming KIF5B and RET gene fusion in lung adenocarcinoma revealed from whole-genome and transcriptome sequencing. Genome Res 2012;22:436-445.
6. Li F, Feng Y, Fang R, et al. Identification of RET gene fusion by exon array analyses in "pan-negative" lung cancer from never smokers. Cell Res 2012;22:928-931.
7. Lipson D, Capelletti M, Yelensky R, et al. Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies. Nat Med 2012;18:382-384.
8. Drilon A, Wang L, Hasanovic A, et al. Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas. Cancer Discov 2013;3:630-635.
9. Enomoto H, Crawford PA, Gorodinsky A, et al. RET signaling is essential for migration, axonal growth and axon guidance of developing sympathetic neurons. Development 2001;128:3963-3974.
10. Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996;276:1575-1579.
11. Jasim S, Ying AK, Waguespack SG, et al. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid 2011;21:189-192.
12. Futami H, Egawa S, Tsukada T, et al. A novel somatic point mutation of the RET Proto-oncogene in tumor tissues of small cell lung cancer patients. Jpn J Cancer Res 1995;86:1127-1130.
13. Mulligan LM, Timmer T, Ivanchuk SM, et al. Investigation of the genes for RET and its ligand complex, GDNF/GFR alpha-I, in small cell lung carcinoma. Genes Chromosomes Cancer 1998;21:326-332.
14. Peifer M, Fernández-Cuesta L, Sos ML, et al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat Genet 2012;44:1104-1110.
15. Rudin CM, Durinck S, Stawiski EW, et al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat Genet 2012;44:1111-1116.